vs
CLOVER HEALTH INVESTMENTS, CORP.（CLOV）与Fabrinet（FN）财务数据对比。点击上方公司名可切换其他公司
Fabrinet的季度营收约是CLOVER HEALTH INVESTMENTS, CORP.的1.5倍（$1.1B vs $749.2M），Fabrinet净利率更高（9.9% vs 3.6%，领先6.3%），CLOVER HEALTH INVESTMENTS, CORP.同比增速更快（62.0% vs 35.9%），过去两年CLOVER HEALTH INVESTMENTS, CORP.的营收复合增速更高（45.0% vs 24.4%）
克利弗健康投资公司是2014年成立的美国医疗保健企业，主营联邦医疗保险优势计划保险产品，是与美国政府直接签约合作的机构。目前公司为美国11个州的联邦医疗保险参保人提供健康管理服务，并已于2021年1月8日公开上市。
Fabrinet（股票代码FN）为标普中型股400指数成分股。该指数由标普道琼斯指数公司维护，覆盖400家以美企为主的中等市值企业，若成分企业存在多类流通股，指数的成分股总量有时会超过400只。
CLOV vs FN — 直观对比
营收规模更大
FN
是对方的1.5倍
$749.2M
营收增速更快
CLOV
高出26.1%
35.9%
净利率更高
FN
高出6.3%
3.6%
两年增速更快
CLOV
近两年复合增速
24.4%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $749.2M | $1.1B |
| 净利润 | $27.3M | $112.6M |
| 毛利率 | — | 12.2% |
| 营业利润率 | 3.6% | 10.1% |
| 净利率 | 3.6% | 9.9% |
| 营收同比 | 62.0% | 35.9% |
| 净利润同比 | — | 30.0% |
| 每股收益（稀释后） | $0.05 | $3.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLOVFN
| Q1 26 | $749.2M | — | ||
| Q4 25 | $487.7M | $1.1B | ||
| Q3 25 | $496.6M | $978.1M | ||
| Q2 25 | $477.6M | $909.7M | ||
| Q1 25 | $462.3M | $871.8M | ||
| Q4 24 | $337.0M | $833.6M | ||
| Q3 24 | $331.0M | $804.2M | ||
| Q2 24 | $356.3M | $753.3M |
净利润CLOVFN
| Q1 26 | $27.3M | — | ||
| Q4 25 | $-49.3M | $112.6M | ||
| Q3 25 | $-24.4M | $95.9M | ||
| Q2 25 | $-10.6M | $87.2M | ||
| Q1 25 | $-1.3M | $81.3M | ||
| Q4 24 | $-22.1M | $86.6M | ||
| Q3 24 | $-9.2M | $77.4M | ||
| Q2 24 | $7.4M | $81.1M |
毛利率CLOVFN
| Q1 26 | — | — | ||
| Q4 25 | — | 12.2% | ||
| Q3 25 | — | 11.9% | ||
| Q2 25 | — | 12.2% | ||
| Q1 25 | — | 11.7% | ||
| Q4 24 | — | 12.1% | ||
| Q3 24 | 24.5% | 12.3% | ||
| Q2 24 | 30.3% | 12.3% |
营业利润率CLOVFN
| Q1 26 | 3.6% | — | ||
| Q4 25 | -10.1% | 10.1% | ||
| Q3 25 | -4.9% | 9.6% | ||
| Q2 25 | -2.2% | 9.8% | ||
| Q1 25 | -0.3% | 9.0% | ||
| Q4 24 | -6.4% | 9.5% | ||
| Q3 24 | -2.7% | 9.6% | ||
| Q2 24 | 2.0% | 9.7% |
净利率CLOVFN
| Q1 26 | 3.6% | — | ||
| Q4 25 | -10.1% | 9.9% | ||
| Q3 25 | -4.9% | 9.8% | ||
| Q2 25 | -2.2% | 9.6% | ||
| Q1 25 | -0.3% | 9.3% | ||
| Q4 24 | -6.6% | 10.4% | ||
| Q3 24 | -2.8% | 9.6% | ||
| Q2 24 | 2.1% | 10.8% |
每股收益（稀释后）CLOVFN
| Q1 26 | $0.05 | — | ||
| Q4 25 | — | $3.11 | ||
| Q3 25 | — | $2.66 | ||
| Q2 25 | — | $2.41 | ||
| Q1 25 | — | $2.25 | ||
| Q4 24 | — | $2.38 | ||
| Q3 24 | — | $2.13 | ||
| Q2 24 | — | $2.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $177.6M | $960.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $339.4M | $2.2B |
| 总资产 | $697.7M | $3.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CLOVFN
| Q1 26 | $177.6M | — | ||
| Q4 25 | $78.3M | $960.8M | ||
| Q3 25 | — | $968.8M | ||
| Q2 25 | — | $934.2M | ||
| Q1 25 | — | $950.7M | ||
| Q4 24 | $194.5M | $934.6M | ||
| Q3 24 | $288.0M | $908.9M | ||
| Q2 24 | $254.8M | $858.6M |
股东权益CLOVFN
| Q1 26 | $339.4M | — | ||
| Q4 25 | $308.7M | $2.2B | ||
| Q3 25 | $340.9M | $2.1B | ||
| Q2 25 | $344.2M | $2.0B | ||
| Q1 25 | $336.1M | $1.9B | ||
| Q4 24 | $341.1M | $1.8B | ||
| Q3 24 | $342.2M | $1.8B | ||
| Q2 24 | $324.9M | $1.7B |
总资产CLOVFN
| Q1 26 | $697.7M | — | ||
| Q4 25 | $541.0M | $3.3B | ||
| Q3 25 | $559.7M | $3.0B | ||
| Q2 25 | $575.0M | $2.8B | ||
| Q1 25 | $583.7M | $2.6B | ||
| Q4 24 | $580.7M | $2.5B | ||
| Q3 24 | $653.0M | $2.4B | ||
| Q2 24 | $674.2M | $2.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $46.3M |
| 自由现金流经营现金流 - 资本支出 | — | $-5.3M |
| 自由现金流率自由现金流/营收 | — | -0.5% |
| 资本支出强度资本支出/营收 | — | 4.6% |
| 现金转化率经营现金流/净利润 | — | 0.41× |
| 过去12个月自由现金流最近4个季度 | — | $102.3M |
8季度趋势，按日历期对齐
经营现金流CLOVFN
| Q1 26 | — | — | ||
| Q4 25 | $-66.9M | $46.3M | ||
| Q3 25 | $12.1M | $102.6M | ||
| Q2 25 | $5.4M | $55.1M | ||
| Q1 25 | $-16.3M | $74.2M | ||
| Q4 24 | $34.8M | $115.9M | ||
| Q3 24 | $50.0M | $83.2M | ||
| Q2 24 | $44.8M | $83.1M |
自由现金流CLOVFN
| Q1 26 | — | — | ||
| Q4 25 | $-69.0M | $-5.3M | ||
| Q3 25 | $11.4M | $57.3M | ||
| Q2 25 | $4.8M | $4.7M | ||
| Q1 25 | $-16.5M | $45.7M | ||
| Q4 24 | $33.3M | $94.0M | ||
| Q3 24 | $49.6M | $62.9M | ||
| Q2 24 | $44.4M | $70.4M |
自由现金流率CLOVFN
| Q1 26 | — | — | ||
| Q4 25 | -14.1% | -0.5% | ||
| Q3 25 | 2.3% | 5.9% | ||
| Q2 25 | 1.0% | 0.5% | ||
| Q1 25 | -3.6% | 5.2% | ||
| Q4 24 | 9.9% | 11.3% | ||
| Q3 24 | 15.0% | 7.8% | ||
| Q2 24 | 12.5% | 9.3% |
资本支出强度CLOVFN
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | 4.6% | ||
| Q3 25 | 0.1% | 4.6% | ||
| Q2 25 | 0.1% | 5.5% | ||
| Q1 25 | 0.0% | 3.3% | ||
| Q4 24 | 0.5% | 2.6% | ||
| Q3 24 | 0.1% | 2.5% | ||
| Q2 24 | 0.1% | 1.7% |
现金转化率CLOVFN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.41× | ||
| Q3 25 | — | 1.07× | ||
| Q2 25 | — | 0.63× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | 1.34× | ||
| Q3 24 | — | 1.07× | ||
| Q2 24 | 6.04× | 1.02× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLOV
暂无分部数据
FN
| Optical Communications | $832.6M | 73% |
| Non Optical Communications | $300.3M | 27% |
